Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels
Håkansson, J.
Lakartidningen 108(22-23): 1234-1235
2011
ISSN/ISBN: 0023-7205 PMID: 21786497 Document Number: 652358
Document emailed within 1 workday
Related Documents
Simoons, M.L.; Casparie, A.F. 1998: Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO Nederlands Tijdschrift Voor Geneeskunde 142(38): 2096-2101Konstantinov, V.O. 2017: The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications Kardiologiia 57(5): 68-72
Wagner, M.; Goetghebeur, M.; Merikle, E.; Pandya, A.; Chu, P.; Taylor, D.C.A. 2009: Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada Canadian Journal of Clinical Pharmacology 16(2): E331-E345
McKenna, C.J.; Sugrue, D.D. 1995: Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives Irish Medical Journal 88(6): 191
Stokes, T.; Shukla, R.; Monk, P. 1996: Secondary prevention of meningococcal disease. No evidence exists to support use of penicillin Bmj 312(7045): 1536-1537
Jost, S.; Lichtlen, P.R. 1995: Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease Zeitschrift für Kardiologie 84(8): 577-595
1986: Lowering of cholesterol levels in fat imbalance disorders Medizinische Monatsschrift für Pharmazeuten 9(9): 274-276
Enas, E.A.; Pazhoor, H.C.; Kuruvila, A.; Vijayaraghavan, K. 2011: Intensive statin therapy for Indians: Part-I. Benefits Indian Heart Journal 63(3): 211-227
Fretheim, A.; Bjørndal, A.; Oxman, A.D.; Dyrdal, A.; Golding, M.; Ose, L.; Reikvam, A.; Teisberg, P. 2002: Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(23): 2287-2288
Tachibana, E.; Watanabe, I.; Nagao, K.; Kanmatsuse, K. 2000: Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients Journal of Cardiology 35(4): 277-285
Ali, F.; Laurin, M.-Y.; Larivière, C.; Tremblay, D.; Cloutier, D. 2003: The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels Canadian Journal of Clinical Pharmacology 10(3): 101-106
Simoons, M.L. 2000: Cholesterol-lowering therapy; a recommendation from the Health Council Nederlands tijdschrift voor geneeskunde 144(51): 2442-2444
Simoons, M.L.; Deckers, J.W. 2015: LDL cholesterol lowering therapy: no target value but personalised treatment Nederlands Tijdschrift Voor Geneeskunde 159: A8770
Paragh, G.; Balogh, Z.; Boda, J.; Mohácsi, A.; Kovács, P.; Polgár, P.; Wórum, F.; Kakuk, G. 1997: Lipid lowering treatment in secondary prevention following myocardial infarct Orvosi Hetilap 138(29): 1849-1853
Otterstad, J.E.; Hexeberg, E.; Holme, I.; Hjermann, I. 1997: Cholesterol lowering therapy after myocardial infarction. Consequences of the CARE study Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(16): 2341-2344
2003: After several years of statin therapy. Long-term prevention of cardiac death MMW Fortschritte der Medizin 145(8): 56
Liu, L-Ping.; Wang, Y-Jun. 2011: Strengthening the role of statin therapy in atherosclerosis for the prevention and treatment of cerebrovascular disease Zhonghua Nei Ke Za Zhi 50(4): 275-277
2005: Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source MMW Fortschritte der Medizin 147(23): 48-49
Hoppichler, F.; Lechleitner, M.; Patsch, J.R. 1992: Pravastatin, a new cholesterol synthesis inhibitor for lowering increased serum cholesterol Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(11): 523-527
Moyad, M.A.; Merrick, G.S. 2006: Cholesterol, cholesterol lowering agents/statins, and urologic disease: part i - knowing your numbers Urologic Nursing 26(2): 156-159